The chart above plots the price of GEN over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 59 sessions over that window: $25.81 on 29 May 2026 through $28.93 on 21 August 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 26, 2026
GEN insider trades
SEC Form 4 · last 90 days · newest reported trade 21 Aug 2026
Open-market buys1
Open-market sells5
Net sold$7.47M
Non-trade filings2
DateInsiderTypeSharesValue
21 Aug 2026Vlcek OndrejDirectorSell47,462$1.38M
19 Aug 2026Vlcek OndrejDirectorSell100,000$2.80M
17 Aug 2026Witteveen Travis MichaelHead of Products and PortfolioSell440$12K
10 Aug 2026Witteveen Travis MichaelHead of Products and PortfolioSell30,000$883K
10 Jun 2026Vlcek OndrejDirectorSell100,000$2.48M
04 Jun 2026Chrystal John CDirectorBuy3,000$81K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
15 Aug 2026Witteveen Travis MichaelHead of Products and PortfolioAward440$11K
01 Jun 2026Vlcek OndrejDirectorTax withheld128$4K
GEN reported financials
SEC EDGAR XBRL
GEN reported revenue of $5.0B for the fiscal year ended 03 Apr 2026. Net income over the same period was $973.0M.
FigureReportedPeriod
Revenue
$5.0B
03 Apr 2026 fiscal year
Net income
$973.0M
03 Apr 2026 fiscal year
Diluted EPS
$1.57
03 Apr 2026 fiscal year
Total assets
$15.6B
03 Jul 2026 at period end
Total equity
$2.7B
03 Jul 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 03 Jul 2026
GEN earnings
SEC EDGAR
DatePeriodEPSRevenue
03 Jul 2026Q1 2027$0.36—
03 Apr 2026FY 2026$1.57—
02 Jan 2026Q3 2026$0.31—
03 Oct 2025Q2 2026$0.21—
04 Jul 2025Q1 2026$0.22—
28 Mar 2025FY 2025$1.03—
27 Dec 2024Q3 2025$0.26—
27 Sep 2024Q2 2025$0.26—
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
10 of the 45 institutional funds we track reported a GEN position for the quarter ended 30 Jun 2026 — a combined $106.5M; the latest of those filings landed 14 Aug 2026.